Rockefeller Capital Management
PRCT icon

Rockefeller Capital Management’s Procept Biorobotics PRCT Stock Holding History

Rockefeller Capital Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.07M Buy
313,030
+14,630
+5% +$366K 0.01% 829
2026
Q1 		$7.46M Buy
298,400
+70,214
+31% +$1.98M 0.01% 776
2025
Q4 		$7.18M Buy
228,186
+220,115
+2,727% +$7.3M 0.01% 768
2025
Q3 		$288K Buy
+8,071
New +$369K ﹤0.01% 2040

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Rockefeller Capital Management's PRCT Position: Q2 2026 in Review

Rockefeller Capital Management increased its Procept Biorobotics (PRCT) stake by 4.9% in Q2 2026, buying an estimated $366K and bringing the position to 313,030 shares worth $7.07M. The position accounts for 0.01% of the portfolio, ranked #829.

Rockefeller Capital Management first reported a position in PRCT in Q3 2025 and has held it in 4 quarters since. The position peaked at $7.46M in Q1 2026. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Rockefeller Capital Management held 313,030 shares of Procept Biorobotics worth $7.07M as of Q2 2026.
  • Rockefeller Capital Management bought 14,630 Procept Biorobotics shares in Q2 2026, an estimated $366K.
  • Procept Biorobotics made up 0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #829 holding.
  • Rockefeller Capital Management first reported a position in Procept Biorobotics in Q3 2025 and has held it in 4 quarters since.
  • Rockefeller Capital Management's Procept Biorobotics position peaked at $7.46M in Q1 2026.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.